CMS Updates Guidelines for F329 Unnecessary Drugs

PharmacyerrorThe Centers for Medicare and Medicaid Services (CMS) recently issued additional regulatory guidelines for F329 Unnecessary Drugs, with a special focus on use of antipsychotic medications for residents diagnosed with behavioral or psychological symptoms of dementia. The CMS release advises that all antipsychotic medications carry Food and Drug Administration Black Box Warnings. These warnings caution [...]

2016-12-21T11:39:00+00:00January 20th, 2016|